{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T11:41:21Z","timestamp":1784893281741,"version":"3.55.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,11,23]],"date-time":"2023-11-23T00:00:00Z","timestamp":1700697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,11,23]],"date-time":"2023-11-23T00:00:00Z","timestamp":1700697600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"the Key Science and Technology Foundation of Henan Province","award":["212102310049"],"award-info":[{"award-number":["212102310049"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pregnancy Childbirth"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The objective of this study was to investigate the optimal controlled ovarian hyperstimulation (COH) protocol for patients aged 35 and above with poor ovarian response (POR), utilizing real-world data. This retrospective cohort study examined clinical information from a total of 4256 patients between January 2017 and November 2022. The patients were categorized into three groups: modified GnRH agonist protocol (2116 patients), GnRH antagonist protocol (1628 patients), and Mild stimulation protocol (512 patients). Comparative analysis was conducted on clinical variables and pregnancy outcomes across the three groups. The GnRH agonist protocol was associated with a higher number of oocyte number (4.02\u2009\u00b1\u20092.25 vs. 3.15\u2009\u00b1\u20091.52 vs. 2.40\u2009\u00b1\u20091.26, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001), higher number of transferable embryos (1.73\u2009\u00b1\u20091.02 vs. 1.35\u2009\u00b1\u20091.22 vs. 1.10\u2009\u00b1\u20090.86, <jats:italic>p<\/jats:italic>\u2009=\u20090.016), higher cumulative live birth rate 28.50(603\/2116) vs. 24.94(406\/1628) vs. 20.51(105\/512), <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001) than GnRH antagonist protocol and Mild stimulation protocol, the Mild stimulation protocol was associated with a higher miscarriage rates 16.27(62\/381) vs. 16.61(48\/289) vs. 32.22(29\/90), <jats:italic>p<\/jats:italic>\u2009=\u20090.001) than the other two groups. Therefore, it can be concluded that all three protocols can be used in patients over 35 years old with poor ovarian response. However, if patients require more frozen-thawed embryo transfers to achieve better cumulative live birth rates, the modified GnRH agonist protocol may be the preferable option.<\/jats:p>","DOI":"10.1186\/s12884-023-06112-4","type":"journal-article","created":{"date-parts":[[2023,11,23]],"date-time":"2023-11-23T12:03:00Z","timestamp":1700740980000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Analysis of controlled ovarian hyperstimulation protocols in women over 35 years old with poor ovarian response: a real-world study"],"prefix":"10.1186","volume":"23","author":[{"given":"Xiaoyan","family":"Duan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingming","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,11,23]]},"reference":[{"key":"6112_CR1","doi-asserted-by":"publisher","first-page":"2911","DOI":"10.12688\/f1000research.10382.1","volume":"5","author":"P Humaidan","year":"2016","unstructured":"Humaidan P, Alviggi C, Fischer R, Esteves SC. The novel POSEIDON stratification of \u2018Low prognosis patients in assisted Reproductive Technology\u2019 and its proposed marker of successful outcome. F1000Research. 2016;5:2911.","journal-title":"F1000Research"},{"key":"6112_CR2","doi-asserted-by":"publisher","first-page":"263349412094148","DOI":"10.1177\/2633494120941480","volume":"14","author":"P Drakopoulos","year":"2020","unstructured":"Drakopoulos P, Bardhi E, Boudry L, Vaiarelli A, Makrigiannakis A, Esteves S, Tournaye H, Blockeel C. Update on the management of poor ovarian response in IVF: the shift from Bologna criteria to the Poseidon concept. Therapeutic Adv Reproductive Health. 2020;14:2633494120941480.","journal-title":"Therapeutic Adv Reproductive Health"},{"key":"6112_CR3","doi-asserted-by":"crossref","unstructured":"Abu-Musa A, Haahr T, Humaidan P. Novel physiology and definition of poor ovarian response; clinical recommendations. Int J Mol Sci. 2020;21(6).","DOI":"10.3390\/ijms21062110"},{"issue":"1","key":"6112_CR4","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1186\/s12884-022-05152-6","volume":"22","author":"L Hua","year":"2022","unstructured":"Hua L, Zhe Y, Jing Y, Fujin S, Jiao C, Liu L. Prediction model of gonadotropin starting dose and its clinical application in controlled ovarian stimulation. BMC Pregnancy Childbirth. 2022;22(1):810.","journal-title":"BMC Pregnancy Childbirth"},{"key":"6112_CR5","doi-asserted-by":"publisher","first-page":"461","DOI":"10.3389\/fendo.2018.00461","volume":"9","author":"SC Esteves","year":"2018","unstructured":"Esteves SC, Roque M, Bedoschi GM, Conforti A, Humaidan P, Alviggi C. Defining low prognosis patients undergoing assisted Reproductive Technology: POSEIDON Criteria-The why. Front Endocrinol (Lausanne). 2018;9:461.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"6112_CR6","doi-asserted-by":"publisher","first-page":"1072313","DOI":"10.3389\/fendo.2022.1072313","volume":"13","author":"L Han","year":"2022","unstructured":"Han L, Tian H, Guo X, Zhang L. Regulation of ovarian function by growth hormone: potential intervention of ovarian aging. Front Endocrinol. 2022;13:1072313.","journal-title":"Front Endocrinol"},{"key":"6112_CR7","doi-asserted-by":"publisher","first-page":"387","DOI":"10.3389\/fendo.2019.00387","volume":"10","author":"A Conforti","year":"2019","unstructured":"Conforti A, Esteves SC, Cimadomo D, Vaiarelli A, Di Rella F, Ubaldi FM, Zullo F, De Placido G, Alviggi C. Management of women with an unexpected low ovarian response to Gonadotropin. Front Endocrinol (Lausanne). 2019;10:387.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"6112_CR8","doi-asserted-by":"publisher","first-page":"589","DOI":"10.3389\/fendo.2018.00589","volume":"9","author":"C Alviggi","year":"2018","unstructured":"Alviggi C, Conforti A, Esteves SC, Vallone R, Venturella R, Staiano S, Castaldo E, Andersen CY, De Placido G. Understanding ovarian hypo-response to Exogenous Gonadotropin in Ovarian Stimulation and its new proposed marker-the Follicle-To-Oocyte (FOI) index. Front Endocrinol (Lausanne). 2018;9:589.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"6112_CR9","doi-asserted-by":"publisher","first-page":"1071014","DOI":"10.3389\/fmed.2023.1071014","volume":"10","author":"D Zhao","year":"2023","unstructured":"Zhao D, Xie R, Li X. Comparison of pregnancy outcome after fresh embryo transfer between GnRH antagonist and GnRH agonist regimens in patients with thin endometrium. Front Med. 2023;10:1071014.","journal-title":"Front Med"},{"issue":"1","key":"6112_CR10","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1186\/s12884-021-03849-8","volume":"21","author":"M Xia","year":"2021","unstructured":"Xia M, Zheng J. Comparison of clinical outcomes between the depot gonadotrophin-releasing hormone agonist protocol and gonadotrophin-releasing hormone antagonist protocol in normal ovarian responders. BMC Pregnancy Childbirth. 2021;21(1):372.","journal-title":"BMC Pregnancy Childbirth"},{"key":"6112_CR11","doi-asserted-by":"publisher","first-page":"182","DOI":"10.3389\/fendo.2020.00182","volume":"11","author":"R Orvieto","year":"2020","unstructured":"Orvieto R, Kirshenbaum M, Galiano V, Elkan-Miller T, Zilberberg E, Haas J, Nahum R. Stop GnRH-Agonist combined with multiple-dose GnRH-Antagonist protocol for patients with genuine poor response undergoing controlled ovarian hyperstimulation for IVF. Front Endocrinol (Lausanne). 2020;11:182.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"6112_CR12","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1186\/s12884-022-05295-6","volume":"22","author":"J Gui","year":"2022","unstructured":"Gui J, Ni Y, Liu Q, Wang X, Xie Q. Comparison of clinical effects between early follicular prolonged GnRH agonist protocol and GnRH antagonist protocol in 3310 cycles: a retrospective study. BMC Pregnancy Childbirth. 2022;22(1):942.","journal-title":"BMC Pregnancy Childbirth"},{"issue":"2","key":"6112_CR13","first-page":"82","volume":"4","author":"S Gordts","year":"2012","unstructured":"Gordts S, Van Turnhout C, Campo R, Puttemans P, Valkenburg M, Gordts S. A prospective randomised study comparing a GnRH-antagonist versus a GnRH-agonist short protocol for ovarian stimulation in patients referred for IVF. Facts Views & Vision in ObGyn. 2012;4(2):82\u20137.","journal-title":"Facts Views & Vision in ObGyn"},{"issue":"1","key":"6112_CR14","doi-asserted-by":"publisher","first-page":"4456","DOI":"10.1038\/s41598-022-08400-z","volume":"12","author":"S Kadoura","year":"2022","unstructured":"Kadoura S, Alhalabi M, Nattouf AH. Conventional GnRH antagonist protocols versus long GnRH agonist protocol in IVF\/ICSI cycles of polycystic ovary syndrome women: a systematic review and meta-analysis. Sci Rep. 2022;12(1):4456.","journal-title":"Sci Rep"},{"key":"6112_CR15","doi-asserted-by":"publisher","first-page":"875779","DOI":"10.3389\/fendo.2022.875779","volume":"13","author":"J Zhu","year":"2022","unstructured":"Zhu J, Xing W, Li T, Lin H, Ou J. GnRH Antagonist Protocol Versus GnRH Agonist Long Protocol: a retrospective cohort study on clinical outcomes and maternal-neonatal safety. Front Endocrinol (Lausanne). 2022;13:875779.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"6112_CR16","doi-asserted-by":"publisher","first-page":"905263","DOI":"10.3389\/fendo.2022.905263","volume":"13","author":"R Gao","year":"2022","unstructured":"Gao R, Liao X, Huang W, Zeng R, Qin L, Bai P. Follicular-phase GnRH agonist protocol is another choice for polycystic ovary syndrome patients with lower LH\/FSH and lower AMH levels without increasing severe OHSS risk. Front Endocrinol (Lausanne). 2022;13:905263.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"4","key":"6112_CR17","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1080\/09513590.2018.1528221","volume":"35","author":"Y Geng","year":"2019","unstructured":"Geng Y, Xun Y, Hu S, Lai Q, Jin L. GnRH antagonist versus follicular-phase single-dose GnRH agonist protocol in patients of normal ovarian responses during controlled ovarian stimulation. Gynecol Endocrinol. 2019;35(4):309\u201313.","journal-title":"Gynecol Endocrinol"},{"key":"6112_CR18","doi-asserted-by":"publisher","first-page":"385049","DOI":"10.1155\/2015\/385049","volume":"2015","author":"M Stimpfel","year":"2015","unstructured":"Stimpfel M, Vrtacnik-Bokal E, Pozlep B, Virant-Klun I. Comparison of GnRH agonist, GnRH antagonist, and GnRH antagonist mild protocol of controlled ovarian hyperstimulation in good prognosis patients. Int J Endocrinol. 2015;2015:385049.","journal-title":"Int J Endocrinol"},{"issue":"6","key":"6112_CR19","doi-asserted-by":"publisher","first-page":"2327","DOI":"10.1177\/0300060518770346","volume":"46","author":"R Yu","year":"2018","unstructured":"Yu R, Jin H, Huang X, Lin J, Wang P. Comparison of modified agonist, mild-stimulation and antagonist protocols for in vitro fertilization in patients with diminished ovarian reserve. J Int Med Res. 2018;46(6):2327\u201337.","journal-title":"J Int Med Res"},{"issue":"4","key":"6112_CR20","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.rbmo.2018.01.008","volume":"36","author":"Y Cohen","year":"2018","unstructured":"Cohen Y, Tannus S, Alzawawi N, Son WY, Dahan M, Buckett W. Poor ovarian response as a predictor for live birth in older women undergoing IVF. Reprod Biomed Online. 2018;36(4):435\u201341.","journal-title":"Reprod Biomed Online"},{"issue":"3","key":"6112_CR21","first-page":"230","volume":"23","author":"Z Basirat","year":"2019","unstructured":"Basirat Z, Kashifard M, Golsorkhtabaramiri M, Mirabi P. Factors associated with spontaneous abortion following intracytoplasmic sperm injection (ICSI). JBRA Assist Reprod. 2019;23(3):230\u20134.","journal-title":"JBRA Assist Reprod"},{"issue":"1","key":"6112_CR22","doi-asserted-by":"publisher","first-page":"11368","DOI":"10.1038\/s41598-021-90970-5","volume":"11","author":"F Li","year":"2021","unstructured":"Li F, Niu A, Feng X, Yan Y, Chen Y. The threshold effect of factors associated with spontaneous abortion in human-assisted reproductive technology. Sci Rep. 2021;11(1):11368.","journal-title":"Sci Rep"},{"issue":"7","key":"6112_CR23","first-page":"15","volume":"26","author":"BA Hassan","year":"2022","unstructured":"Hassan BA, Elmugabil A, Alhabrdi NA, Ahmed ABA, Rayis DA, Adam I. Maternal age and miscarriage: a unique association curve in Sudan. Afr J Reprod Health. 2022;26(7):15\u201321.","journal-title":"Afr J Reprod Health"},{"issue":"1","key":"6112_CR24","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1093\/humrep\/14.1.18","volume":"14","author":"S Bussen","year":"1999","unstructured":"Bussen S, S\u00fctterlin M, Steck T. Endocrine abnormalities during the follicular phase in women with recurrent spontaneous abortion. Hum Reprod (Oxford England). 1999;14(1):18\u201320.","journal-title":"Hum Reprod (Oxford England)"},{"issue":"3","key":"6112_CR25","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1016\/j.fertnstert.2010.11.062","volume":"95","author":"I Souter","year":"2011","unstructured":"Souter I, Baltagi L, Kuleta D, Meeker J, Petrozza J. Women, weight, and fertility: the effect of body mass index on the outcome of superovulation\/intrauterine insemination cycles. Fertil Steril. 2011;95(3):1042\u20137.","journal-title":"Fertil Steril"},{"issue":"3","key":"6112_CR26","first-page":"556","volume":"32","author":"M Toftager","year":"2017","unstructured":"Toftager M, Bogstad J, L\u00f8ssl K, Pr\u00e6torius L, Zedeler A, Bryndorf T, Nilas L, Pinborg A. Cumulative live birth rates after one ART cycle including all subsequent frozen-thaw cycles in 1050 women: secondary outcome of an RCT comparing GnRH-antagonist and GnRH-agonist protocols. Hum Reprod. 2017;32(3):556\u201367.","journal-title":"Hum Reprod"},{"issue":"5","key":"6112_CR27","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.5114\/aoms.2019.85145","volume":"15","author":"L Tian","year":"2019","unstructured":"Tian L, Tan J, Zou Y, Su Q, Li Y, Xu D, Wu Q. Mild starting dosage ovarian stimulation combined with a modified prolonged GnRH-a protocol improved IVF\/ICSI outcomes in normal ovarian responders. Archives of Medical Science: AMS. 2019;15(5):1294\u2013300.","journal-title":"Archives of Medical Science: AMS"},{"issue":"4","key":"6112_CR28","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/j.fertnstert.2020.07.022","volume":"114","author":"C Bergh","year":"2020","unstructured":"Bergh C, Kamath MS, Wang R, Lensen S. Strategies to reduce multiple pregnancies during medically assisted reproduction. Fertil Steril. 2020;114(4):673\u20139.","journal-title":"Fertil Steril"},{"issue":"2","key":"6112_CR29","first-page":"156","volume":"156","author":"JM Madrazo-Cabo","year":"2020","unstructured":"Madrazo-Cabo JM, Le\u00f3n-Dur\u00e1n GA, Oliveros-Montiel A, Ledesma-Montes JA, Morales-Gonz\u00e1lez ID, Sede\u00f1o-Monge V. Complications in pregnancies achieved by assisted reproduction. Gac Med Mex. 2020;156(2):156\u201363.","journal-title":"Gac Med Mex"},{"key":"6112_CR30","doi-asserted-by":"publisher","first-page":"831859","DOI":"10.3389\/fendo.2022.831859","volume":"13","author":"M Yan","year":"2022","unstructured":"Yan M, Cao J, Hou J, Jiang W, Wang D, Sun Z, Song J. GnRH agonist and hCG (dual trigger) versus hCG trigger for final oocyte maturation in Expected Normal Responders with a high immature oocyte rate: Study Protocol for a Randomized, superiority, Parallel Group, Controlled Trial. Front Endocrinol. 2022;13:831859.","journal-title":"Front Endocrinol"},{"issue":"1","key":"6112_CR31","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.rbmo.2018.03.013","volume":"37","author":"P Lehert","year":"2018","unstructured":"Lehert P, Chin W, Schertz J, D\u2019Hooghe T, Alviggi C, Humaidan P. Predicting live birth for poor ovarian responders: the PROsPeR concept. Reprod Biomed Online. 2018;37(1):43\u201352.","journal-title":"Reprod Biomed Online"},{"issue":"5","key":"6112_CR32","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1016\/j.rbmo.2020.08.003","volume":"41","author":"R Yang","year":"2020","unstructured":"Yang R, Zhang C, Chen L, Wang Y, Li R, Liu P, Qiao J. Cumulative live birth rate of low prognosis patients with POSEIDON stratification: a single-centre data analysis. Reprod Biomed Online. 2020;41(5):834\u201344.","journal-title":"Reprod Biomed Online"},{"issue":"5","key":"6112_CR33","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1007\/s10815-013-9975-3","volume":"30","author":"MF Mutlu","year":"2013","unstructured":"Mutlu MF, Erdem M, Erdem A, Yildiz S, Mutlu I, Arisoy O, Oktem M. Antral follicle count determines poor ovarian response better than anti-M\u00fcllerian hormone but age is the only predictor for live birth in in vitro fertilization cycles. J Assist Reprod Genet. 2013;30(5):657\u201365.","journal-title":"J Assist Reprod Genet"},{"key":"6112_CR34","doi-asserted-by":"crossref","unstructured":"Canosa S, Carosso AR, Mercaldo N, Ruffa A, Evangelista F, Bongioanni F, Benedetto C, Revelli A, Gennarelli G. Effect of rLH supplementation during controlled ovarian stimulation for IVF: evidence from a retrospective analysis of 1470 Poor\/Suboptimal\/Normal responders receiving either rFSH plus rLH or rFSH alone. J Clin Med. 2022;11(6).","DOI":"10.3390\/jcm11061575"},{"issue":"7","key":"6112_CR35","doi-asserted-by":"publisher","first-page":"146","DOI":"10.21037\/atm.2019.04.16","volume":"7","author":"L Shu","year":"2019","unstructured":"Shu L, Xu Q, Meng Q, Dai X, Zhang Y, Zhou W, Yi H, Liu J, Wu C, Hou Z, et al. Clinical outcomes following long GnRHa ovarian stimulation with highly purified human menopausal gonadotropin plus rFSH or rFSH in patients undergoing in vitro fertilization-embryo transfer: a multi-center randomized controlled trial. Annals of Translational Medicine. 2019;7(7):146.","journal-title":"Annals of Translational Medicine"},{"issue":"7","key":"6112_CR36","doi-asserted-by":"publisher","first-page":"2033","DOI":"10.31557\/APJCP.2019.20.7.2033","volume":"20","author":"L Safdarian","year":"2019","unstructured":"Safdarian L, Aghahosseini M, Alyasin A, Samaei Nouroozi A, Rashidi S, Shabani Nashtaei M, Najafian A, Lak P. Growth hormone (GH) improvement of ovarian responses and pregnancy outcome in poor ovarian responders: a randomized study. Asian Pac J cancer Prevention: APJCP. 2019;20(7):2033\u20137.","journal-title":"Asian Pac J cancer Prevention: APJCP"},{"key":"6112_CR37","doi-asserted-by":"publisher","first-page":"1040503","DOI":"10.3389\/fendo.2022.1040503","volume":"13","author":"C Chang","year":"2022","unstructured":"Chang C, Sung Y, Hsueh Y, Chen Y, Ho M, Hsu H, Yang T, Lin W, Chang H. Growth hormone in fertility and infertility: mechanisms of action and clinical applications. Front Endocrinol. 2022;13:1040503.","journal-title":"Front Endocrinol"},{"issue":"6","key":"6112_CR38","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.bj.2019.05.003","volume":"42","author":"K Lan","year":"2019","unstructured":"Lan K, Lin P, Chang Y, Chen Y, Tsai Y, Ismaeil Mohamed I, Kang H. Growth hormone supplementation may improve the pregnancy rate and endometrial receptivity among women aged more than 40 years undergoing in vitro fertilization. Biomedical J. 2019;42(6):411\u20136.","journal-title":"Biomedical J"}],"container-title":["BMC Pregnancy and Childbirth"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-023-06112-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12884-023-06112-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-023-06112-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,23]],"date-time":"2023-11-23T12:03:27Z","timestamp":1700741007000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpregnancychildbirth.biomedcentral.com\/articles\/10.1186\/s12884-023-06112-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,23]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["6112"],"URL":"https:\/\/doi.org\/10.1186\/s12884-023-06112-4","relation":{},"ISSN":["1471-2393"],"issn-type":[{"value":"1471-2393","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,23]]},"assertion":[{"value":"7 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 November 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of the First People\u2019s Hospital of Shangqiu (SQ20190016). The study was a retrospective cohort, and the requirement for informed consent was waived by the Medical Ethics Committee of the First People\u2019s Hospital of Shangqiu.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"813"}}